How much revenue does GeneLink make?

GeneLink reported $2.14 million in revenue for fiscal year 2012, down 54.4% from $4.68 million in fiscal year 2011. In Q3 2013 revenue was $294,739.

What companies are similar to GeneLink?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Wuhan General Group (China), Inc. (WUHN), James E. Wagner Cultivation Corporation (JWCAF), Industry Source Consulting, Inc. (INSO), VIA Pharmaceuticals, Inc. (VIAP).

GeneLink, Inc. (GNLKQ) Stock

About GeneLink, Inc.

GeneLink, Inc. offers 12-gene DNA assessment services. The company also provides health custom supplements. In addition, it formulates a line of skin care products. The company was founded in 1994 and is based in Orlando, Florida.

At a glance

GeneLink reported revenue of $2.14 million for fiscal year 2012, down 54.4% from fiscal year 2011, and net income of -$3.05 million. In Q3 2013 (the quarter ended September 30, 2013) revenue was $294,739, down 30.7% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2012.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.